Search

A recent study conducted at the Islamic University of Gaza examined the relationship between type 1 diabetes and polycystic ovary syndrome (PCOS) in women. The study found that women with type 1 diabetes who received intensive insulin treatment were more likely to develop PCOS and experience symptoms such as oligomenorrhea, hyperinsulinemia, and hyperandrogenemia. The research suggests that the administration of supra-physiological doses of insulin may stimulate androgen synthesis, leading to the development of PCOS in women with type 1 diabetes. This study provides valuable insights into the impact of diabetes on women's health and highlights the need for further research in this area. [Extracted from the article]

A study conducted by researchers at the SRM Institute of Science and Technology aimed to investigate the relationship between temperature living conditions, stress levels, sleeping duration, and secondary oligomenorrhea (infrequent menstrual cycles). The study involved a diverse group of women aged 18 to 23 years who had experienced secondary oligomenorrhea. The findings revealed correlations between temperature conditions and menstrual cycle length, as well as a negative correlation between sleeping duration and menstrual cycle length. The impact of stress on secondary oligomenorrhea varied depending on temperature conditions. The study highlights the need for a holistic approach when addressing this menstrual disorder. [Extracted from the article]

This document provides information about a clinical study that is currently recruiting participants. The study aims to investigate the use of infrared thermal imaging and pain threshold examinations of acupoints in patients with premature ovarian insufficiency (POI) and healthy subjects. The study will involve at least three infrared thermal imaging examinations and pain threshold examinations for all participants. The study is open to both male and female participants aged 18 to 40 years. The contact information for the primary investigator is provided for those interested in participating. [Extracted from the article]

A study conducted at Hebei General Hospital in China examined the relationship between lipid-lowering drugs and female reproductive endocrine diseases. The researchers focused on three drug targets of statins and conducted a drug-targeted Mendelian randomization analysis to investigate the effects of these inhibitors on reproductive endocrine diseases. The study found that PCSK9 inhibitors significantly increased the risk of infertility in patients, while HMGCR inhibitors reduced the risk of menorrhagia (excessive menstrual bleeding) in female patients. However, no effects of lipid-lowering drugs were observed on other reproductive endocrine disorders. [Extracted from the article]

Endocrine System Diseases and Conditions, Health and Medicine, Oligomenorrhea, Polycystic Ovary Syndrome, Women's Health Keywords: Endocrine System Diseases and Conditions; Health and Medicine; Oligomenorrhea; Polycystic Ovary Syndrome; Women's Health EN Endocrine System Diseases and Conditions Health and Medicine Oligomenorrhea Polycystic Ovary Syndrome Women's Health 4305 4305 1 07/10/23 20230714 NES 230714 2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on polycystic ovary syndrome are presented in a new report. [Extracted from the article]

Adnexal Diseases and Conditions, Cardiology, Cardiovascular, Cardiovascular Diseases and Conditions, Cardiovascular Research, Endocrine System Diseases and Conditions, Endocrinology, Female Urogenital Diseases and Conditions, Gonadal Disorders, Health and Medicine, Hyperandrogenism, Oligomenorrhea, Ovarian Cysts, Ovarian Diseases and Conditions, Polycystic Ovary Syndrome, Risk and Prevention, Syndromes, Women's Health Keywords: Adnexal Diseases and Conditions; Cardiology; Cardiovascular; Cardiovascular Diseases and Conditions; Cardiovascular Research; Endocrine System Diseases and Conditions; Endocrinology; Female Urogenital Diseases and Conditions; Gonadal Disorders; Health and Medicine; Hyperandrogenism; Oligomenorrhea; Ovarian Cysts; Ovarian Diseases and Conditions; Polycystic Ovary Syndrome; Risk and Prevention; Syndromes; Women's Health EN Adnexal Diseases and Conditions Cardiology Cardiovascular Cardiovascular Diseases and Conditions Cardiovascular Research Endocrine System Diseases and Conditions Endocrinology Female Urogenital Diseases and Conditions Gonadal Disorders Health and Medicine Hyperandrogenism Oligomenorrhea Ovarian Cysts Ovarian Diseases and Conditions Polycystic Ovary Syndrome Risk and Prevention Syndromes Women's Health 857 857 1 06/26/23 20230626 NES 230626 2023 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- A new study on polycystic ovary syndrome is now available. [Extracted from the article]

The article focuses on menstruation, which may have a significant impact on the quality of life on women. Topics include the common issues in menstruation which include dysmenorrhea, oligomenorrhoea, and the premenstrual syndrome (PMS). It adds that changes in menstrual cycle are due to some factors which include sudden weight gain or loss, anxiety or stress, and dietary changes.

The article presents a case study of a woman suffering from juvenile myoclonic epilepsy and developing oligomenorrhoea due to the treatment of levetiracetam.

The article provides answers to questions on post-baby periods including timing for periods, getting pregnant before periods and irregular periods.

The article discusses research being done on the association of irregular menstrual periods with asthma and lung function. It references a study by Francisco Gómez Real and colleagues published in the September 2007 issue of the "Journal of Allergy and Clinical Immunology." One of the clinical implications of the study is that women with oligomenorrhea and other symptoms of metabolic disturbance should be examined with regard to respiratory health.

The article presents a study which examined the treatment of infertility caused by polycystic ovary syndrome (PCOS). PCOS is considered a common cause of infertility. It is characterized by hyperandrogenemia and oligomenorrhea. According to the author, the results of this study do not negate the use of insulin sensitizers for the general treatment of women with PCOS. The findings show that treatment of infertility in women with PCOS is best achieved by the use of clomiphene citrate.

The article discusses the treatment of poly cystic ovarian syndrome (PCOS) through homeopathy. Topics discussed include failure of expulsion of maturing eggs from the ovary thereby filling ovary with immature follicles, role of abnormal levels of both female and male hormones in resulting oligomenorrhea, and effectiveness of homeopathy in the regularization of menstrual cycles.

The article presents a case report of a female patient who experienced hyperprolactinemia, weight gain and lipid metabolism disorders after receiving risperidone. A laparotomy enucleation of the tumor was performed after she was diagnosed with a right ovary teratoma. She was also given aripiprazole. Following the treatment, the patient's oligomenorrhea and breast swelling were resolved.

Discusses research being done on the effects of oral contraceptives on body composition and physical performance in female athletes. Reference to a study by A. Rickenlund et al published in the September 2004 issue of the "Journal of Clinical Endocrinology and Metabolism"; Baselines where the oligo-/amenorrhoeic athlete group experienced increases; Side effect that were observed among regularly menstruating athletes.